Skip to main content

Global Minimally Invasive Cardiac Surgery Market: Evolving Demands and 5–10% CAGR by 2030

 


The minimally invasive cardiac surgery market is projected to grow at a 5-10% CAGR over the forecast period. Major factors driving growth include increased prevalence of cardiovascular diseases (CVDs), rising demand for minimally invasive cardiac procedures, growing aging population, patient preference for minimally invasive procedures, technological advancement in minimally invasive cardiac surgery, shift towards outpatient and ambulatory surgery centers (ASCs), and rising awareness about cardiovascular health conditions. 

Minimally invasive cardiac surgery (MICS), sometimes referred to as keyhole heart surgery, is a sophisticated technique used to perform heart bypass procedures for treating coronary heart disease. In this approach, the surgeon uses specialized surgical instruments to access the heart through a small incision on the left side of the chest. Unlike traditional open-heart surgery, which requires opening the chest cavity, MICS allows access through the natural spaces between the ribs without the need for cutting. This method is less invasive, resulting in reduced trauma and quicker patient recovery.

Download a free sample report for in-depth market insights
https://meditechinsights.com/minimally-invasive-cardiac-surgery-market/request-sample/

Growing demand for minimally invasive cardiac surgery procedures fuels its demand

Minimally invasive cardiac procedures have revolutionized heart surgery by offering safer and less invasive alternatives to traditional open-heart techniques. The adoption of these methods is rapidly growing, driven by the need to reduce patient trauma, shorten recovery times, and lower healthcare costs. Procedures like cardiac catheterization and percutaneous coronary intervention are increasingly preferred due to their significant benefits over conventional approaches. These techniques utilize specialized cardiology devices, such as catheters, stents, and guidewires, which are witnessing rising demand. Moreover, minimally invasive approaches are widely applied in various cardiac surgeries, including mitral valve repair, coronary artery bypass grafting, and aortic valve replacement, further accelerating market growth.

Shift towards minimally invasive cardiac surgery over traditional heart surgery drives market growth

Minimally invasive cardiac surgery (MICS) has transformed the treatment of various heart conditions, offering a safer and equally effective alternative to traditional open-heart surgery. It provides several significant advantages over conventional methods:

  • Smaller Incisions & Less Pain: With minimal incisions on the breastbone, MICS reduces post-operative pain and scarring. This approach also preserves chest function and improves breathing after surgery
  • Faster Recovery & Return to Daily Activities: Unlike traditional heart surgeries, MICS allows patients to resume normal activities, such as driving and working, much sooner often immediately after the initial recovery phase
  • Minimal Blood Loss & Reduced Need for Transfusion: The use of robotic instruments and small incisions minimizes blood loss during the procedure, significantly lowering the need for transfusions and reducing the risk of blood-borne infections
  • Lower Risk of Post-Surgical Infections: Due to the smaller incisions, MICS greatly decreases the likelihood of infections, making it particularly beneficial for diabetic and elderly patients with weaker immune systems
  • Minimal Scarring & Faster Healing: With incisions as small as 2-4 inches, scarring is virtually non-existent, leading to quicker wound healing with fewer complications
  • Shorter Hospital Stays: One of the greatest advantages of MICS is the reduced recovery period. Patients typically stay in the hospital for about five days, compared to nine days for those undergoing traditional open-heart surgery, enabling a faster return to normal life with less rehabilitative care.

By combining advanced surgical techniques with enhanced patient outcomes, MICS continues to redefine the landscape of modern cardiac surgery.

Competitive Landscape Analysis

The global minimally invasive cardiac surgery market is marked by the presence of established and emerging market players such as Abbott Laboratories; Intuitive Surgical; Stryker Corporation; GE HealthCare; Edwards Lifesciences Corporation; Siemens Healthineers; Terumo Corporation; Johnson & Johnson; Philips Healthcare; Medtronic; Boston Scientific Corporation; Zimmer Biomet; Smith & Nephew; Olympus Corporation; and Micro Interventional Devices (MID); among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.

Unlock key data with a sample report for competitive analysis:
https://meditechinsights.com/minimally-invasive-cardiac-surgery-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global minimally invasive cardiac surgery market at the regional- and country-level from 2023 to 2030. The report further segments the market based on surgery type, procedure type, and end user.

  • Market Size & Forecast (2023-2030), By Surgery Type, USD Million
    • Robotic-assisted Surgery
    • Thoracoscopy Surgery
  • Market Size & Forecast (2023-2030), By Procedure Type, USD Million
    • Aortic Valve Repair/Replacement
    • Mitral Valve Repair/Replacement
    • Surgical Radiofrequency Ablation for Atrial Fibrillation
    • Tricuspid Valve Repair or Replacement
    • Atrial Septal Defect (ASD)
    • Ventricular Assist Device (VAD) Implantation
    • Coronary Artery Bypass Grafting (CABG)
    • Other Procedures
  • Market Size & Forecast (2023-2030), By End User, USD Million
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Speciality Clinics
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 
info@meditechinsights.com 

Comments

Popular posts from this blog

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...

Hospital Capacity Management Solutions Market Forecast Shows Strong 18% CAGR Growth Rate by 2030

  The Global Hospital Capacity Management Solutions Market is set to witness an healthy growth rate of 18% in the next 5 years.  Growing burden of diseases, a corresponding rise in patient volumes, the need for better capacity management in hospitals, adoption fueled by benefits offered by hospital capacity management solutions, the introduction of IoT-enabled devices and technologically advanced solutions, Covid-19, and need to reduce growing healthcare costs are some of the key factors driving the market’s growth. However, concerns related to data security and privacy is likely to impact the growth of the global market. Over the years, there has been an exponential rise in the number of patients and number of diseases globally, which has placed a huge burden on the healthcare sector. To offer better care, curtail escalating healthcare costs and deliver an incomparable patient experience, several hospitals are either deploying hospital capacity management solutions or seek...